Does the sex of acute stroke patients influence the effectiveness of rt-PA?

BMC Neurology

Volumn 14, Issue 1, 2014, Pages

  Al hussain, Fawaz ^a   Hussain, Muhammad S ^b   Molina, Carlos ^c   Uchino, Ken ^b   Shuaib, Ashfaq ^d   Demchuk, Andrew M ^e   Alexandrov, Andrei V ^f   Saqqur, Maher ^d  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b LERNER RESEARCH INSTITUTE   (United States)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

^f University of Alabama at Birmingham   (United States)

Author keywords

Gender; rt PA; Sex; Stroke; Thrombolysis

Indexed keywords

ALTEPLASE; GLUCOSE; FIBRINOLYTIC AGENT; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

AGE; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; RANKIN SCALE; RECANALIZATION; SEX; SEX DIFFERENCE; STROKE PATIENT; SYSTOLIC BLOOD PRESSURE; THROMBOLYSIS IN BRAIN ISCHEMIA FLOW GRADING SYSTEM; TIME TO TREATMENT; TREATMENT OUTCOME; CLINICAL TRIAL; MIDDLE AGED; STROKE;

AGED; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; SEX FACTORS; STROKE; TISSUE PLASMINOGEN ACTIVATOR; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84898838351     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-14-60     Document Type: Article

References (21)

1. The National Institutes of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581-1587. The National Institutes of Neurological Disorders and Stroke rt-PA Stroke Study Group.
2. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000, 283:1145-1150. 10.1001/jama.283.9.1145, 10703776.
3. Demchuk AM, Tanne D, Hill MD, Kasner SE, Hanson S, Grond M, Levine SR, for the Multicentre tPA Stroke Survey Group Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology 2001, 57:474-480. 10.1212/WNL.57.3.474, 11502916, for the Multicentre tPA Stroke Survey Group.
4. Molina CA, Alexander AV, Demchuk AM, Saqqur M, Uchino K, Alvarez-Sabin J, CLOTBUST Investigators Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke 2004, 35:151-156. 10.1161/01.STR.0000128705.63891.67, 14671245, CLOTBUST Investigators.
5. The NINDS, t-PA Stroke Study Group Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA stroke trial. Stroke 1997, 28:2119-2125. 10.1161/01.STR.28.11.2119, 9368551, t-PA Stroke Study Group.
6. Alexandrov AV, Burgin SW, Demchuk AM, El-Mitwalli A, Grotta JC. Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation 2001, 103:2897-2902. 10.1161/01.CIR.103.24.2897, 11413077.
7. Christou I, Alexandrov AV, Burgin WS, Wojner AW, Felberg RA, Malkoff M, Grotta JC. Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke. Stroke 2000, 31:1812-1816. 10.1161/01.STR.31.8.1812, 10926939.
8. Molina CA, Montaner J, Abilleira S, Arenillas JF, Ribo M, Huertas R, Romero F, Alvarez-Sabin J. Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: a case-control study. Stroke 2001, 32:2821-2827. 10.1161/hs1201.99821, 11739980.
9. Kapral MK, Fang J, Hill MD, Silver F, Richards J, Jaigobin C, Cheung AM, Investigators of Registry of the Canadian Stroke Network Sex differences in stroke care and outcomes; results from the registry of the Canadian stroke network. Stroke 2005, 36:809-814. 10.1161/01.STR.0000157662.09551.e5, 15731476, Investigators of Registry of the Canadian Stroke Network.
10. Niewada M, Kabayashi A, Sandercock PA, Kaminski B, Czlonkowska A. Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischemic stroke in the international stroke trial. Neuroepidemiology 2005, 24:123-128. 10.1159/000082999, 15637449.
11. Weimer C, Ziegler A, Konig IR, Diener HC. Predicting functional outcome and survival after acute ischemic stroke. J Neurol 2002, 249:888-895. 10.1007/s00415-002-0755-8, 12140674.
12. Di Carlo A, Lamassa M, Baldereschi M, Pracucci G, Basile AM, Wolfe CDA, Giroud M, Rudd A, Ghetti A, Inzitari D. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe. Data from multicenter multinational hospital based registry. Stroke 2003, 34:1114-1119. 10.1161/01.STR.0000068410.07397.D7, 12690218.
13. Gebara OCE, Mittleman MA, Sutherland P, Lipinska I, Matheney T, Xu P, Welty F, Wilson PWF, Levy D, Muller J, Tofler GH. Association between increased estrogen status and increased fibrinolytic potential in the Framingham offspring study. Circulation 1995, 91:1952-1958. 10.1161/01.CIR.91.7.1952, 7895352.
14. Kent DM, Price LL, Ringleb P, Hill MD, Selker HP. Sex-based differences in response to rt-PA in acute ischemic stroke. A pooled analysis of randomized clinical trials. Stroke 2005, 36:62-65. 10.1161/01.STR.0000150515.15576.29, 15569865.
15. Saposnik G, Di Legge S, Webster F, Hachinski V. Predictors of major neurological improvement after thrombolysis in acute stroke. Neurology 2005, 65:1169-1174. 10.1212/01.wnl.0000180687.75907.4b, 16247041.
16. Savitz SI, Schlaug G, Caplan L, Selim M. Arterial occlusive lesions recanalize more frequently in women than in men after IV t-PA administration for acute stroke. Stroke 2005, 36:1447-1451. 10.1161/01.STR.0000170647.42126.a8, 15947268.
17. Demchuk AM, Burgin WS, Christou I, Felberg RA, Barber PA, Hill MD, Alexandrov AV. Thrombolysis in Brain Ischemia (TIBI) transcranial doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke 2001, 32:89-93. 10.1161/01.STR.32.1.89, 11136920.
18. Demchuk AM, Christou I, Wein TH, Felberg RA, Malkoff M, Grotta JC, Alexandrov AV. Accuracy and criteria for localizing arterial occlusion with transcranial doppler. J Neuroimaging 2000, 10:1-12.
19. Burgin WS, Malkoff M, Felberg RA, Demchuk AM, Christou I, Grotta JC, Alexandrov AV. Transcranial doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke. Stroke 2000, 31:1128-1132. 10.1161/01.STR.31.5.1128, 10797176.
20. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, Montaner J, Saqqur M, Demchuk AM, Moyle LA, Hill MD, Wojner AW, CLOTBUST Investigators Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004, 351:2170-2178. 10.1056/NEJMoa041175, 15548777, CLOTBUST Investigators.
21. Shobha N, Sylaja PN, Kapral MK, Fang J, Hill MD. Differences in stroke outcome based on sex. Neurology 2010, 74:767-771. 10.1212/WNL.0b013e3181d5275c, 2836873, 20194917.